Akira Science

Akira Science is a Swedish deep-tech company focused on developing pliable, 3D-printed, bioresorbable scaffolds and implants for soft tissue engineering, particularly in medical applications like breast reconstruction after oncological surgeries. The company originated as a tech spin-off from the KTH Royal Institute of Technology in Stockholm and utilizes advanced expertise in degradable polymer synthesis and cell-material interaction to create innovative, patient-specific solutions. Their flagship product, AkiMed™, is a bioresorbable breast implant designed to support natural tissue regeneration, providing a more accessible and natural-feeling alternative to traditional reconstruction methods. Akira Science offers pre-made and customized 3D-printed scaffolds, filaments for 3D printing, simulation support for optimizing scaffold designs, and tailored 3D printing protocols. Their multidisciplinary team combines knowledge from various fields, enabling them to innovate in regenerative medicine and bioprocessing. Target customers include medical professionals, biopharmaceutical companies, and corporate partners interested in advanced biomaterials and medical devices. Akira Science aims to enhance patient outcomes and accessibility in reconstructive medicine through their customizable and clinically effective solutions.

• Employees 2
• Founded 2019